At this time, posts about Antrogen are rapidly increasing on portals and securities communities, and today, foreigners are tentatively estimated to have net purchased 16,641 shares. Antrogen is known as a company that develops and sells stem cell therapeutics.
As of 12:30 PM on the 21st, Antrogen's stock price is 61,300 KRW, up 11.05% from the previous day, with a trading volume of 781,423 shares, which is 286.76% of the 5-day average trading volume.
In addition to Antrogen, posts by investors are also surging for Yes24 (053280), Myungmoon Pharmaceutical (017180), and Daehan Scientific (131220).
※Source: AI Investment Assistant AI Rassi
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
